Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region

被引：17

作者：

degli Atti, MLC

Filia, A

Massari, M

Pizzuti, R

Nicoletti, L

D'Argenzio, A

de Campora, E

Marchi, A

Lombardo, A

Salmaso, S

机构：

[1] Ist Super Sanita, Ctr Nazl Epidemiol Sorveglianza & Promoz Salute, Reparto Epidemiol Malattie Infett, I-00161 Rome, Italy

[2] Osservatorio Epidemiol Reg, Naples, Italy

[3] Ist Super Sanita, Dipartimento Malattie Infett, Reparto Malattie Virali & Vaccini Attenuati, I-00161 Rome, Italy

[4] ASL Caserta 2, Aversa, Italy

[5] Agenzia Reg Serv Sanitari, Naples, Italy

来源：

VACCINE | 2006年 / 24卷 / 09期

关键词：

measles epidemic; surveillance; vaccination;

D O I：

10.1016/j.vaccine.2005.09.031

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A large measles epidemic occurred in 2002 in Campania, a region of southern Italy with inadequate vaccination coverage. We evaluated the burden of the outbreak in children < 15 years of age using different data sources. The measles standardized incidence rate was 5757/100,000, corresponding to 63,368 estimated cases (95% CI: 59,544-67,373). Measles virus strains were identified as belonging to the D7 genotype. The estimated complication rate was 7.6%. A total of 972 measles hospitalisations were detected, giving a hospitalisation rate of 88.3/100,000. Three deaths occurred. These results show that measles can still represent a serious health threat even in industrialized Countries. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：1332 / 1338

页数：7

共 28 条

[1]

[Anonymous], 1994, Bull World Health Organ, V72, P885

[2]

[Anonymous], STRAT PLAN MEASL CON

[3] Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy [J].

Atti, MLC ;

Rota, MC ;

Bella, A ;

Salmaso, S ;

Binkin, N ;

Perra, A ;

Bellomo, AR ;

Di Giorgio, G ;

Fiumalbi, C ;

Frizza, J ;

Frongia, O ;

Cassiani, R ;

Salvadei, M ;

Cauzillo, G ;

Locuratolo, F ;

De Filippis, S ;

Basile, C ;

Pizzuti, R ;

Romagna, E ;

Grandori, L ;

Ancarani, C ;

Bertozzi, N ;

Tominz, R ;

Pompa, MG ;

Bellomo, AR ;

Ciuta, ST ;

Crovari, P ;

Icardi, GC ;

De Luca, S ;

Sensi, S ;

Sebastiani, E ;

Frizza, J ;

Grilli, G ;

Carducci, E ;

Di Giorgio, G ;

Kreidl, P ;

Foppa, A ;

Gamper, S ;

Weiss, S ;

Carraro, V ;

Barale, A ;

Lopalco, P ;

Prato, R ;

Novelli, G ;

Fiongia, O ;

Scondotto, S ;

Di Giorgi, M ;

Cernigliaro, A ;

Fiumalbi, C ;

Bidini, G .

VACCINE, 2004, 22 (31-32) :4351-4357

[4]

Atti MLCD, 2002, PEDIATR INFECT DIS J, V21, P763, DOI [10.1097/01.inf.0000023961.12041.2b, 10.1097/00006454-200208000-00013]

[5]

BARON S, 1996, REV EPIDEMIOL SANTE, V44, pS19

[6]

BOVE C, 2002, BEN MARZO

[7] SALIVARY DIAGNOSIS OF MEASLES - A STUDY OF NOTIFIED CASES IN THE UNITED-KINGDOM, 1991-3 [J].

BROWN, DWG ;

RAMSAY, MEB ;

RICHARDS, AF ;

MILLER, E .

BRITISH MEDICAL JOURNAL, 1994, 308 (6935) :1015-1017

[8] The average cost of measles cases and adverse events following vaccination in industrialised countries [J].

Carabin, H ;

Edmunds, WJ ;

Kou, U ;

van den Hof, S ;

Nguyen, VH .

BMC PUBLIC HEALTH, 2002, 2 (1) :1-13

[9]

DEGLIATTI MLC, 2003, MMWR-MORBID MORTAL W, V52, P1044

[10]

FILIA A, 2005, RAPPORTI ISTISAN, V5

← 1 2 3 →